Tenpoint Therapeutics, Ltd. announced that YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is now available in the U.S. for the treatment of presbyopia...
Tenpoint Therapeutics, Ltd. announced that the U.S. Food and Drug Administration (FDA) approved YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as...
LENZ Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye...
HOYA has launched its VisuPro All Day and VisuPro Flex advanced focus spectacle lenses to help young presbyopes, people in their late 30s to mid-40s...